Related references
Note: Only part of the references are listed.Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis Case report and review
Miguel Santin et al.
MEDICINE (2020)
Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS
Claire Rivoisy et al.
JOINT BONE SPINE (2016)
Therapeutics targeting inflammation in the immune reconstitution inflammatory syndrome
Lokesh Shahani et al.
TRANSLATIONAL RESEARCH (2016)
Biologic Agents and Tuberculosis
Claudia C. Dobler
MICROBIOLOGY SPECTRUM (2016)
Immune Reconstitution Inflammatory Syndrome Associated with Biologic Therapy
Malika Gupta et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2015)
Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV- negative patients
G. Geri et al.
INFECTION (2013)
A Life-Threatening Central Nervous System-Tuberculosis Inflammatory Reaction Nonresponsive to Corticosteroids and Successfully Controlled by Infliximab in a Young Patient With a Variant of Juvenile Idiopathic Arthritis
Jaimes-Hernandez Jorge et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2012)
Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent
Steffen Hess et al.
EUROPEAN JOURNAL OF PEDIATRICS (2011)
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome
Graeme Meintjes et al.
AIDS (2010)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Therapeutic Use of Infliximab in Tuberculosis to Control Severe Paradoxical Reaction of the Brain and Lymph Nodes
Timothy K. Blackmore et al.
CLINICAL INFECTIOUS DISEASES (2008)
Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients
VCC Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2003)
Share Paper
